Societe Generale »

Biogen Idec shares owned by Societe Generale

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Societe Generale from 13F filings

Historical chart of Societe Generale investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Societe Generale consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Societe Generale

Quarter filed Position value Share count Share price at filing
2016-06-30 $7.8M 32k 241.82

More positions owned by Societe Generale

Spdr S&p 500 Etf (SPY)
Apple (AAPL)
iShares Russell 2000 Index (IWM)
Amazon (AMZN)
SPDR S&P MidCap 400 ETF (MDY)
Apple Inc option
iShares MSCI EAFE Index Fund (EFA)
McKesson Corporation (MCK)
Mondelez Int (MDLZ)
Bank of America Corporation (BAC)
McDonald's Corporation (MCD)
At&t (T)
iShares MSCI Brazil Index (EWZ)
PowerShares QQQ Trust, Series 1
Alphabet Inc Class C cs (GOOG)

View all positions for Societe Generale

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Wellington Management Company
T. Rowe Price Investment Management
Geode Capital Management
Pacer Advisors
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Legal & General Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec